Ann: Notice of Annual General Meeting/Proxy Form, page-37

Well lots of comments. Some are worrying but I cannot verify for myself so I make no comment on them.

I did some basic search and filtering on Amazon note link:

https://www.amazon.com/s?k=infant+formula+goat+milk&s=exact-aware-popularity-rank&crid=7WGZH3P9EWEG&qid=1729841928&sprefix=infant+formula%2Caps%2C939&ref=aa_sbox_sort&ds=v1%3AivwPd5FTnD3iHVBFWI3hFS4wvukxDVh0BFNxJ2UudHU


What I can see is that, under infant goats formula search by highest average rating, bubs products are still in the top 10 highest rating products. The data doesn't tell product sold but it does correlate that if a product rates high it will sell more than competitors. I see that the price per unit is competitive and that the images show as the old can labels.

I want to see the gain in revenue on the next quarterly report. At the moment I'm against a CR unless I see a substantial increase in US revenue.